tiprankstipranks
Skye Bioscience Approves Incentive Plan Amendments and Leadership Changes
Company Announcements

Skye Bioscience Approves Incentive Plan Amendments and Leadership Changes

Don't Miss our Black Friday Offers:

Skye Bioscience ( (SKYE) ) just unveiled an announcement.

Skye Bioscience, Inc. held a special meeting where stockholders approved an amendment to increase the shares available under the 2014 Omnibus Incentive Plan by 1,535,655 and extend the plan’s expiration to 2034. The plan, now named the Skye Bioscience, Inc. Amended and Restated Omnibus Incentive Plan, also increases the number of incentive stock options to 4,000,000, and was passed with 17.4 million votes in favor against 6.2 million opposed.

Learn more about SKYE stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlySkye Bioscience achieved more than 50% targeted patient enrollment in CBeyond
TipRanks Auto-Generated NewsdeskSkye Bioscience Reports Progress in Obesity Drug Trials
TheFlySkye Bioscience reports Q3 EPS (10c), consensus (25c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App